Rheumatoid arthritis: Management
Evidence in support of early and aggressive pharmacological intervention in rheumatoid arthritis continues to be gathered. DMARDs, corticosteroids and biologics are the main drugs in the armoury
Treatment of rheumatoid arthritis has developed substantially over recent years, reducing the likelihood of deformity and disability. Several of the newer biologic medicines, which act against tumour necrosis factor and other specific targets in the inflammatory response, are now approved by the National Institute for Health and Clinical Excellence and/or the Scottish Medicines Consortium. Disease-modifying antirheumatic drugs and corticosteroids are also used.
Despite these advances many patients still struggle with the condition because their therapy has not been optimised or because of intolerance to drugs. Pharmacists can help patients manage their medicines, advise on side effects and, with specialist training, perform prescribing and monitoring roles.
Richard Copeland is head of clinical pharmacy services at Northumbria Healthcare NHS Trust.
Carole Callaghan is advanced clinical pharmacist, rheumatology, at Western General Hospital, Edinburgh.
Email: [email protected]
Citation: Clinical Pharmacist URI: 11010239
Recommended from Pharmaceutical Press
Now in its twelfth edition, Stockley’s Drug Interactions is still the most comprehensive and authoritative international source of drug interaction information.£240.00
An introduction to the basics of accounting and financial management. Applies these principles to pharmacy practice.£38.00
The 2016 pocket guide to drug interactions and their management, for the busy healthcare professional.£31.00
A practical guide to the drug reactions that affect particular organ systems, and the management of these reactions.£38.00
Disease Management covers the diseases commonly encountered in primary care by system, with common therapeutic issues. Includes case studies and self-assessment sections.£54.00